Pfizer

Overview

Global biopharmaceutical company whose bioprocess R&D spans multiple acquisition legacy systems, exemplifying the industry challenge of data heterogeneity and AI readiness gaps at large scale Pfizer's 25 years of process development history is distributed across multiple legacy systems inherited through acquisitions, with much of the historical data not in a format usable for AI model training and some manufacturing facilities still on paper batch records. Pfizer's acquisition of Wyeth brought a business-oriented development culture that balanced Wyeth's perfectionist science culture, producing a healthier equilibrium between scientific rigor and speed-to-market that serves as a model for the industry. (Segment 1 (00:00-05:00))